EORTC-24982-HNCG

Phase II study on Gemcitabine in Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Trial StatusAll trial activities ended
DatesDate of activation: 02-Apr-01
Closed on : 25-Apr-03
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size29
Number of steps1
DrugGemcitabine
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00017498
EudraCT